• Clinical Trials - Multiple myeloma

    Study Objective Contact
    A Phase 3, Randomized, Double-Blind, Multicenter Study Comparing Oral MLN9708 Plus Lenalidomide and Dexamethasone versus Placebo Plus Lenalidomide and Dexamethasone in Adult Patients with Newly Diagnosed Multiple Myeloma [LCID Study Number: 2014-006] The purpose of this research study is to determine whether adding a new drug, MLN9708, to the combination of lenalidomide and dexamethasone is safe and effective and improves survival in patients with newly diagnosed multiple myeloma. Principal Investigator(s):
    Tarun Kewalramani, MD

    For more information about this Research Study call 781-744-8027.

    Study Coordinator(s):
    Deborah J. Gannon.
    S1304: A Phase II Randomized Study Comparing Two Doses of Carfilzomib (nsc-756640) with Dexamethasone for Multiple Myeloma Patients with Relapsed or Refractory Disease [LCID Study Number: 2014-007] This study aims to evaluate and compare progression free survival of two different doses of carfilzomib with dexamethasone in multiple myeloma patients with relapsed and/or disease that has not responded to treatment. Principal Investigator(s):
    Tarun Kewalramani, MD

    For more information about this Research Study call 781-744-8027.

    Study Coordinator(s):
    Deborah J. Gannon.